Curr Pharm Des 22: 54635476, 2016
HUBERMAN: Do your workouts or play your sport or move about more comfortably
According to a 2024 PMC cardiovascular outcomes study, SGLT2 inhibitors reduce: Risk of cardiovascular death or heart failure hospitalization by 23% Risk of kidney disease progression by 45% Blood pressure by 35 mmHg systolic Body weight by 23 kg on average For Indian diabetic patients who already have some of the highest rates of heart disease in the world these numbers are extremely significant
Superoxide anion chemistry-its role at the core of the innate immunity
PlexusDx's Precision Peptide Genetic Test identifies these variants and maps 14 metabolic pathways, revealing whether you may need higher, lower, or modified dosing for optimal results
Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice